148 related articles for article (PubMed ID: 12183265)
1. Predicting evolution by in vitro evolution requires determining evolutionary pathways.
Hall BG
Antimicrob Agents Chemother; 2002 Sep; 46(9):3035-8. PubMed ID: 12183265
[TBL] [Abstract][Full Text] [Related]
2. Predicting evolutionary potential: in vitro evolution accurately reproduces natural evolution of the tem beta-lactamase.
Barlow M; Hall BG
Genetics; 2002 Mar; 160(3):823-32. PubMed ID: 11901104
[TBL] [Abstract][Full Text] [Related]
3. Initial mutations direct alternative pathways of protein evolution.
Salverda ML; Dellus E; Gorter FA; Debets AJ; van der Oost J; Hoekstra RF; Tawfik DS; de Visser JA
PLoS Genet; 2011 Mar; 7(3):e1001321. PubMed ID: 21408208
[TBL] [Abstract][Full Text] [Related]
4. Probing the active site of beta-lactamase R-TEM1 by informational suppression.
Lenfant F; Labia R; Masson JM
Biochimie; 1990; 72(6-7):495-503. PubMed ID: 2124150
[TBL] [Abstract][Full Text] [Related]
5. Predicting the emergence of antibiotic resistance by directed evolution and structural analysis.
Orencia MC; Yoon JS; Ness JE; Stemmer WP; Stevens RC
Nat Struct Biol; 2001 Mar; 8(3):238-42. PubMed ID: 11224569
[TBL] [Abstract][Full Text] [Related]
6. Rapid evolution of a protein in vitro by DNA shuffling.
Stemmer WP
Nature; 1994 Aug; 370(6488):389-91. PubMed ID: 8047147
[TBL] [Abstract][Full Text] [Related]
7. Substitution of Met-69 by Ala or Gly in TEM-1 beta-lactamase confer an increased susceptibility to clavulanic acid and other inhibitors.
Madec S; Blin C; Krishnamoorthy R; Picard B; Chaibi el B; Fouchereau-Péron M; Labia R
FEMS Microbiol Lett; 2002 May; 211(1):13-6. PubMed ID: 12052544
[TBL] [Abstract][Full Text] [Related]
8. Construction and characterization of mutants of the TEM-1 beta-lactamase containing amino acid substitutions associated with both extended-spectrum resistance and resistance to beta-lactamase inhibitors.
Stapleton PD; Shannon KP; French GL
Antimicrob Agents Chemother; 1999 Aug; 43(8):1881-7. PubMed ID: 10428907
[TBL] [Abstract][Full Text] [Related]
9. A secondary drug resistance mutation of TEM-1 beta-lactamase that suppresses misfolding and aggregation.
Sideraki V; Huang W; Palzkill T; Gilbert HF
Proc Natl Acad Sci U S A; 2001 Jan; 98(1):283-8. PubMed ID: 11114163
[TBL] [Abstract][Full Text] [Related]
10. Systematic mutagenesis of the active site omega loop of TEM-1 beta-lactamase.
Petrosino JF; Palzkill T
J Bacteriol; 1996 Apr; 178(7):1821-8. PubMed ID: 8606154
[TBL] [Abstract][Full Text] [Related]
11. Mutant TEM beta-lactamase producing resistance to ceftazidime, ampicillins, and beta-lactamase inhibitors.
Vakulenko S; Golemi D
Antimicrob Agents Chemother; 2002 Mar; 46(3):646-53. PubMed ID: 11850243
[TBL] [Abstract][Full Text] [Related]
12. The effect of high-frequency random mutagenesis on in vitro protein evolution: a study on TEM-1 beta-lactamase.
Zaccolo M; Gherardi E
J Mol Biol; 1999 Jan; 285(2):775-83. PubMed ID: 9878443
[TBL] [Abstract][Full Text] [Related]
13. Identification of amino acid substitutions that alter the substrate specificity of TEM-1 beta-lactamase.
Palzkill T; Botstein D
J Bacteriol; 1992 Aug; 174(16):5237-43. PubMed ID: 1644749
[TBL] [Abstract][Full Text] [Related]
14. Experimental prediction of the natural evolution of antibiotic resistance.
Barlow M; Hall BG
Genetics; 2003 Apr; 163(4):1237-41. PubMed ID: 12702671
[TBL] [Abstract][Full Text] [Related]
15. Evolution of antibiotic resistance: several different amino acid substitutions in an active site loop alter the substrate profile of beta-lactamase.
Palzkill T; Le QQ; Venkatachalam KV; LaRocco M; Ocera H
Mol Microbiol; 1994 Apr; 12(2):217-29. PubMed ID: 8057847
[TBL] [Abstract][Full Text] [Related]
16. Functional Characterization of CTX-M-14 and CTX-M-15 β-Lactamases by
Po KHL; Chan EWC; Chen S
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971870
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic study of resistance of beta-lactamase-inhibitor-resistant TEM enzymes which differ by naturally occurring variations and by site-directed substitution at Asp276.
Caniça MM; Caroff N; Barthélémy M; Labia R; Krishnamoorthy R; Paul G; Dupret JM
Antimicrob Agents Chemother; 1998 Jun; 42(6):1323-8. PubMed ID: 9624468
[TBL] [Abstract][Full Text] [Related]
18. RAISE: a simple and novel method of generating random insertion and deletion mutations.
Fujii R; Kitaoka M; Hayashi K
Nucleic Acids Res; 2006; 34(4):e30. PubMed ID: 16493137
[TBL] [Abstract][Full Text] [Related]
19. Multiple global suppressors of protein stability defects facilitate the evolution of extended-spectrum TEM β-lactamases.
Brown NG; Pennington JM; Huang W; Ayvaz T; Palzkill T
J Mol Biol; 2010 Dec; 404(5):832-46. PubMed ID: 20955714
[TBL] [Abstract][Full Text] [Related]
20. Natural Variants of the KPC-2 Carbapenemase have Evolved Increased Catalytic Efficiency for Ceftazidime Hydrolysis at the Cost of Enzyme Stability.
Mehta SC; Rice K; Palzkill T
PLoS Pathog; 2015 Jun; 11(6):e1004949. PubMed ID: 26030609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
